×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IBRX – immunitybio, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IBRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/20
08:30 am
ibrx
ImmunityBio Partners with Biopharma and Cigalah Healthcare to Launch ANKTIVA® in Saudi Arabia for Bladder and Lung Cancer Patients
Low
Report
ImmunityBio Partners with Biopharma and Cigalah Healthcare to Launch ANKTIVA® in Saudi Arabia for Bladder and Lung Cancer Patients
2/19
08:06 pm
ibrx
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX
2/19
09:00 am
ibrx
ImmunityBio Expands Access to ANKTIVA® in EU with New Distribution Partnership and Opens Irish Subsidiary to Support European Launch
Medium
Report
ImmunityBio Expands Access to ANKTIVA® in EU with New Distribution Partnership and Opens Irish Subsidiary to Support European Launch
2/19
08:02 am
ibrx
ImmunityBio (IBRX) Is Up 29.0% After EU Clears First ANKTIVA+BCG Immunotherapy For NMIBC CIS [Yahoo! Finance]
Low
Report
ImmunityBio (IBRX) Is Up 29.0% After EU Clears First ANKTIVA+BCG Immunotherapy For NMIBC CIS [Yahoo! Finance]
2/19
06:34 am
ibrx
ImmunityBio's EU Anktiva Nod Sparks Questions On Valuation And Momentum [Yahoo! Finance]
Low
Report
ImmunityBio's EU Anktiva Nod Sparks Questions On Valuation And Momentum [Yahoo! Finance]
2/19
06:28 am
ibrx
ImmunityBio (IBRX) Soars to New High on Anktiva Future Expansion [Yahoo! Finance]
Low
Report
ImmunityBio (IBRX) Soars to New High on Anktiva Future Expansion [Yahoo! Finance]
2/18
07:46 pm
ibrx
ImmunityBio (IBRX) Clinical Trial for Lymphona Drug Follows $505M Convertible Note Change [Yahoo! Finance]
Low
Report
ImmunityBio (IBRX) Clinical Trial for Lymphona Drug Follows $505M Convertible Note Change [Yahoo! Finance]
2/18
09:00 am
ibrx
ImmunityBio Receives Authorization from the European Commission for ANKTIVA® with BCG for Non-Muscle Invasive Bladder Cancer Carcinoma in Situ, Expanding Global Access to 33 Countries
High
Report
ImmunityBio Receives Authorization from the European Commission for ANKTIVA® with BCG for Non-Muscle Invasive Bladder Cancer Carcinoma in Situ, Expanding Global Access to 33 Countries
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/18
09:03 am
ibrx
Form 8-K ImmunityBio, Inc. For: Feb 18
High
Report
Form 8-K ImmunityBio, Inc. For: Feb 18
2/12
09:29 pm
ibrx
Form 4 ImmunityBio, Inc. For: Feb 10 Filed by: SOON-SHIONG PATRICK
High
Report
Form 4 ImmunityBio, Inc. For: Feb 10 Filed by: SOON-SHIONG PATRICK
2/12
08:51 pm
ibrx
Form 4 ImmunityBio, Inc. For: Feb 10 Filed by: LAUER REGAN J
High
Report
Form 4 ImmunityBio, Inc. For: Feb 10 Filed by: LAUER REGAN J
2/12
08:51 pm
ibrx
Form 4 ImmunityBio, Inc. For: Feb 10 Filed by: Sachs David C.
High
Report
Form 4 ImmunityBio, Inc. For: Feb 10 Filed by: Sachs David C.
2/12
08:50 pm
ibrx
Form 4 ImmunityBio, Inc. For: Feb 10 Filed by: Adcock Richard
High
Report
Form 4 ImmunityBio, Inc. For: Feb 10 Filed by: Adcock Richard
1/26
07:01 am
ibrx
Form 8-K ImmunityBio, Inc. For: Jan 23
Medium
Report
Form 8-K ImmunityBio, Inc. For: Jan 23
1/21
08:35 pm
ibrx
Form 4 ImmunityBio, Inc. For: Jan 20 Filed by: Simon Barry J.
Medium
Report
Form 4 ImmunityBio, Inc. For: Jan 20 Filed by: Simon Barry J.
1/21
08:34 pm
ibrx
Form 4 ImmunityBio, Inc. For: Jan 16 Filed by: Selecky Christobel
Medium
Report
Form 4 ImmunityBio, Inc. For: Jan 16 Filed by: Selecky Christobel
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: